Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laham

Showing results (491-500 of 611) with videos related to

Pageof 62
Sort By:
Biochemical Pharmacology|April 22, 2024
Generation and characterization of cytochrome P450 3A74 CRISPR/Cas9 knockout bovine foetal hepatocyte cell line (BFH12)Silvia Iori, Caterina D'Onofrio, Nihay Laham-Karam, et al.
Saudi Medical Journal|June 3, 2024
Prevalence of thyroid disorders among the diabetic population in Arar, Saudi ArabiaHaider O Elmisbah, Riyad Y Laham, Hafiz O Almisbah, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 27, 2024
Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathologySuvi Jauhiainen, Favour C Onyeogaziri, Francesca Lazzaroni, et al.
The American Journal of Cardiology|October 9, 2023
Echocardiographic and Clinical Outcomes in Symptomatic Patients With Less Than Severe Aortic Stenosis After Supra-Annular Self-Expanding Transcatheter Aortic Valve ReplacementRavi K Sharma, Roger J Laham, Paul Sorajja, et al.
JAMA Internal Medicine|February 5, 2019
Evaluation of Changes in Functional Status in the Year After Aortic Valve ReplacementDae Hyun Kim, Jonathan Afilalo, Sandra M Shi, et al.
Haematologica|January 9, 2025
High-dose intravenous immunoglobulin may be an efficient treatment option for patients with late-onset high-grade immune effector cell-associated hematotoxicity refractory to standard therapiesYousef Laham, Shimrit Ringelstein-Harlev, Daniel Kurnik, et al.
Surgery|August 10, 2004
Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factorPierre Voisine, Cesario Bianchi, Marc Ruel, et al.
Molecular Psychiatry|June 29, 2021
Atypical perineuronal nets in the CA2 region interfere with social memory in a mouse model of social dysfunctionElise C Cope, Anna D Zych, Nicole J Katchur, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|April 1, 2026
The Utility of Cerebral Protection Devices in Transcatheter Aortic Valve Replacement: A Systematic Review and Bayesian Meta-analysisTomonari M Shimoda, Yosuke Sakurai, Minami Watanabe, et al.
Journal of the American College of Cardiology|December 29, 2000
Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation studyR J Laham, N A Chronos, M Pike, et al.
Pageof 62

Showing results (491-500 of 611) with videos related to

Sort By:
Pageof 62
Biochemical Pharmacology|April 22, 2024
Generation and characterization of cytochrome P450 3A74 CRISPR/Cas9 knockout bovine foetal hepatocyte cell line (BFH12)Silvia Iori, Caterina D'Onofrio, Nihay Laham-Karam, et al.
Saudi Medical Journal|June 3, 2024
Prevalence of thyroid disorders among the diabetic population in Arar, Saudi ArabiaHaider O Elmisbah, Riyad Y Laham, Hafiz O Almisbah, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 27, 2024
Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathologySuvi Jauhiainen, Favour C Onyeogaziri, Francesca Lazzaroni, et al.
The American Journal of Cardiology|October 9, 2023
Echocardiographic and Clinical Outcomes in Symptomatic Patients With Less Than Severe Aortic Stenosis After Supra-Annular Self-Expanding Transcatheter Aortic Valve ReplacementRavi K Sharma, Roger J Laham, Paul Sorajja, et al.
JAMA Internal Medicine|February 5, 2019
Evaluation of Changes in Functional Status in the Year After Aortic Valve ReplacementDae Hyun Kim, Jonathan Afilalo, Sandra M Shi, et al.
Haematologica|January 9, 2025
High-dose intravenous immunoglobulin may be an efficient treatment option for patients with late-onset high-grade immune effector cell-associated hematotoxicity refractory to standard therapiesYousef Laham, Shimrit Ringelstein-Harlev, Daniel Kurnik, et al.
Surgery|August 10, 2004
Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factorPierre Voisine, Cesario Bianchi, Marc Ruel, et al.
Molecular Psychiatry|June 29, 2021
Atypical perineuronal nets in the CA2 region interfere with social memory in a mouse model of social dysfunctionElise C Cope, Anna D Zych, Nicole J Katchur, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|April 1, 2026
The Utility of Cerebral Protection Devices in Transcatheter Aortic Valve Replacement: A Systematic Review and Bayesian Meta-analysisTomonari M Shimoda, Yosuke Sakurai, Minami Watanabe, et al.
Journal of the American College of Cardiology|December 29, 2000
Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation studyR J Laham, N A Chronos, M Pike, et al.
Pageof 62